- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03507504
REspectful CAring for the AGitated Elderly (RECAGE)
REspectful CAring for the AGitated Elderly. How to Best Meet the Needs of People With Dementia With Severe Behavioural Disturbances. Toward a Respectful and Cost-effective Model
Study Overview
Detailed Description
Two cohorts of 250 patients each will be recruited by six clinical centres endowed with a SCU-B (one cohort) and six centres lacking this structure. The follow-up will last 3 years, during which patients will be visited every 6 months and submitted to a battery exploring the severity of the BPSD and the quality of life. All adverse events will be registered, as well as some anticipated occurrences (admissions to the general hospital for intercurrent diseases, admissions to a SCU-B pertaining to the clinical participating centre and, if any, admissions to a SCU-B not pertaining to the Consortium member, nursing home placement).
At the same time the quality of life of the primary caregivers will be measured, as well as their attitude toward dementia.
A cost-effectiveness analysis will be performed comparing the cohorts. Finally the time to the nursing home placement will be recorded and compared between the two cohorts
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Carla Finocchiaro, Ph.D.
- Phone Number: +390231083323
- Email: carla.finocchiaro@cf-c.it
Study Contact Backup
- Name: Sara Fascendini, M.D.
- Phone Number: +390353065206
- Email: recage@ferbonlus.com
Study Locations
-
-
-
Bruxelles, Belgium
- Not yet recruiting
- Centre Hospitalier Universitaire St Pierre
-
Contact:
- Jean P Praet, M.D.
- Phone Number: +3225354118
- Email: jean-philippe_praet@stpierre-bru.be
-
-
-
-
-
Paris, France
- Not yet recruiting
- Assistance Publique - Hôpitaux de Paris
-
Contact:
- Jacques Hugon, M.D.
- Phone Number: +33149958484
- Email: jacques.hugon@inserm.fr
-
-
-
-
-
Berlin, Germany
- Recruiting
- Charité - Universitätsmedizin Berlin
-
Contact:
- Oliver Peters, M.D.
- Phone Number: +4930450517942
- Email: oliver.peters@charite.de
-
-
Baden-Wurttenberg
-
Mannheim, Baden-Wurttenberg, Germany
- Not yet recruiting
- Zentralinstitut für seelische Gesundheit
-
Contact:
- Lutz Froelich, M.D.
- Phone Number: +4962117033001
- Email: lutz.froelich@zi-mannheim.de
-
-
-
-
-
Thessaloníki, Greece
- Recruiting
- Aristotelio Panepistimio Thessalonikis (Greece)
-
Contact:
- Magda Tsolaki, M.D.
- Email: tsolakim1@gmail.com
-
Contact:
- Phone Number: +302310234239
-
-
-
-
BG
-
Bergamo, BG, Italy
- Not yet recruiting
- Cliniche Gavazzeni SpA
-
Contact:
- Paola Merlo, M.D.
- Phone Number: +390354204668
- Email: paola.merlo@gavazzeni.it
-
Gazzaniga, BG, Italy, 24020
- Recruiting
- Fondazione Europea di Ricerca Biomedica
-
Contact:
- Sara Fascendini, M.D.
- Phone Number: +390353065206
- Email: recage@ferbonlus.com
-
Contact:
- Federica Barocco, M.D.
- Phone Number: +390353065206
- Email: federica.barocco@ferbonlus.com
-
-
MN
-
Mantova, MN, Italy
- Recruiting
- Azienda Socio Sanitaria Territoriale di Mantova
-
Contact:
- Alfonso Ciccone, M.D.
- Phone Number: +390376201543
- Email: alfonso.ciccone@asst-mantova.it
-
-
MO
-
Modena, MO, Italy
- Not yet recruiting
- Azienda Unità Sanitaria Locale di Modena
-
Contact:
- Andrea Fabbo, M.D.
- Phone Number: +39059435201
- Email: a.fabbo@ausl.mo.it
-
-
PG
-
Perugia, PG, Italy
- Not yet recruiting
- Università degli Studi di Perugia
-
Contact:
- Patrizia Mecocci, M.D.
- Phone Number: +390755783270
- Email: patrizia.mecocci@unipg.it
-
-
-
-
-
Ottestad, Norway
- Not yet recruiting
- Sykehuset Innlandet
-
Contact:
- Sverre Bergh, M.D.
- Phone Number: +4745679393
- Email: sverre.bergh@sykehuset-innlandet.no
-
-
-
-
-
Genève, Switzerland
- Not yet recruiting
- Université de Genève
-
Contact:
- Giovanni B Frisoni, M.D.
- Phone Number: +410223055762
- Email: giovanni.frisoni@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- diagnosis of primary dementia (DSM IV)
- MMSE score ≤ 24
- NPI global score ≥ 32/144
- a caregiver (informal/family member or formal caregiver) who commits her/himself to accompany the patient along the three-year course of the study
- living at home (nursing home residents are excluded).
Exclusion Criteria:
- presence of uncontrolled medical disease potentially contributing to the cognitive decline and BPSD
- concomitant psychiatric disorders or chronic alcoholism
- concomitant diseases severe enough to reduce life expectancy < 6 months
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
care pathway with SCU-B
250 patients with dementia and behavioural and psychological symptoms of dementia (BPSD) followed up by six clinical centres with a Special Care Unit for BPSD (SCU-B)
|
SCU-B is "a residential medical structure lying outside of a nursing home, in a general hospital or elsewhere, e.g. in a private hospital, where patients with BPSD are temporarily admitted when their behavioural disturbances are not amenable to control at home".
|
care pathway without SCU-B
250 patients with dementia and BPSD followed up by six clinical centres without SCU-B
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of BPSD
Time Frame: baseline, 6, 12, 18, 24, 30, 36 months
|
Neuropsychiatric Inventory (NPI), range 0-144
|
baseline, 6, 12, 18, 24, 30, 36 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
quality of life of patients
Time Frame: baseline, 6, 12,18, 24, 30, 36 months
|
Quality of Life Alzheimer's Disease (QoL-AD), range 0-52
|
baseline, 6, 12,18, 24, 30, 36 months
|
quality of life of caregivers
Time Frame: baseline, 6, 12, 18, 24, 30, 36 months
|
Caregiver Burden Inventory (CBI), range 0-96
|
baseline, 6, 12, 18, 24, 30, 36 months
|
cost-effectiveness of SCU-B
Time Frame: baseline, 6, 12, 18, 24, 30, 36 months
|
Resource Utilisation in Dementia (RUD)
|
baseline, 6, 12, 18, 24, 30, 36 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
delayed institutionalisation
Time Frame: until 3 years
|
Time to nursing home placement
|
until 3 years
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Carlo A Defanti, M.D., Fondazione Europea di Ricerca Biomedica
Publications and helpful links
General Publications
- Koskas P, Belqadi S, Mazouzi S, Daraux J, Drunat O. [Behavioral and psychological symptoms of dementia in a pilot psychogeriatric unit: management and outcomes]. Rev Neurol (Paris). 2011 Mar;167(3):254-9. doi: 10.1016/j.neurol.2010.07.030. Epub 2010 Oct 14. French.
- Delphin-Combe F, Roubaud C, Martin-Gaujard G, Fortin ME, Rouch I, Krolak-Salmon P. [Effectiveness of a cognitive-behavioral unit on behavioral and psychological symptoms of dementia]. Rev Neurol (Paris). 2013 Jun-Jul;169(6-7):490-4. doi: 10.1016/j.neurol.2012.10.017. Epub 2013 Mar 21. French.
- Bianchetti A, Benvenuti P, Ghisla KM, Frisoni GB, Trabucchi M. An Italian model of dementia special care unit: results of a pilot study. Alzheimer Dis Assoc Disord. 1997 Mar;11(1):53-6. doi: 10.1097/00002093-199703000-00009.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H2020 Proposal, number: 779237
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on SCU-B
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
National Institute of Allergy and Infectious Diseases...Dynavax Technologies CorporationActive, not recruitingHIV Infection | Hepatitis BUnited States, Haiti, Botswana, Philippines, Thailand, Brazil, Kenya, Malawi, India, South Africa, Uganda, Vietnam
-
Indiana UniversityAlcon ResearchCompleted
-
PfizerCompletedA Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804Healthy VolunteersBelgium
-
Marya Strand, MDCompletedRespiratory Distress SyndromeUnited States
-
Soroka University Medical CenterCompletedInflammatory Bowel DiseaseIsrael
-
ChemoCentryxMedpace, Inc.CompletedFocal Segmental Glomerulosclerosis | FSGS | GlomerulosclerosisUnited States, France, Italy, Australia, United Kingdom, Canada, New Zealand, Poland
-
Epstein, Arthur B., OD, FAAOAlcon ResearchCompleted
-
Wright State UniversityRecruiting
-
Novo Nordisk A/SCompletedHealthy Volunteers - Haemophilia AGermany